每年出版 6 期
ISSN 打印: 0743-4863
ISSN 在线: 2162-660X
Indexed in
In Vivo Applications of PEG Liposomes: Unexpected Observations
摘要
Recent studies with PEG liposomes in patients have consistently shown that liposomes can induce side effects (flushing, tightness of the chest). Furthermore, the blood clearance of PEG liposomes was shown to be dose-dependent: at lipid doses lower than 1 mmol/kg, PEG liposomes do not show the long-circulation property but instead are cleared relatively rapidly from the bloodstream. Another remarkable observation was that repeated injections of PEG liposomes led to significant pharmacokinetic changes: the circulatory half-life of a second dose of radiolabeled PEG liposomes dramatically decreased when given from 5 days to up to 4 weeks after a first injection. In these three unexpected phenomena, proteins of the complement system seem to play a key role.Therefore, one has to consider that PEG liposomes are not inert drug-carrying vehicles in vivo. Pharmacological effects can occur, induced solely by using liposomal particles irrespective of the drug content.
-
Azzopardi E. A., Ferguson E. L., Thomas D. W., The enhanced permeability retention effect: a new paradigm for drug targeting in infection, Journal of Antimicrobial Chemotherapy, 68, 2, 2013. Crossref
-
Tosi G, Ruozi B, Badiali L, Bondioli L, Belletti D, Forni F, Vandelli M, Immunonanosystems to CNS Pathologies, in Nanotechnology in Health Care, 2012. Crossref
-
Cheema Sangeeta K., Gobin Andrea S., Rhea Robyn, Lopez-Berestein Gabriel, Newman Robert A., Mathur Anshu B., Silk fibroin mediated delivery of liposomal emodin to breast cancer cells, International Journal of Pharmaceutics, 341, 1-2, 2007. Crossref
-
Azzopardi Ernest A., Boyce Dean E., Thomas David W., Dickson William A., Colistin in burn intensive care: Back to the future?, Burns, 39, 1, 2013. Crossref
-
Ohara Yusuke, Oda Tatsuya, Yamada Keiichi, Hashimoto Shinji, Akashi Yoshimasa, Miyamoto Ryoichi, Kobayashi Akihiko, Fukunaga Kiyoshi, Sasaki Ryoko, Ohkohchi Nobuhiro, Effective delivery of chemotherapeutic nanoparticles by depleting host Kupffer cells, International Journal of Cancer, 131, 10, 2012. Crossref
-
Martin Francis, Pegylated Liposome Delivery of Chemotherapeutic Agents, in Modified-Release Drug Delivery Technology, Second Edition, 2008. Crossref
-
Abou Diane S., Thorek Daniel L. J., Ramos Nicholas N., Pinkse Martijn W. H., Wolterbeek Hubert T., Carlin Sean D., Beattie Bradley J., Lewis Jason S., 89Zr-Labeled Paramagnetic Octreotide-Liposomes for PET-MR Imaging of Cancer, Pharmaceutical Research, 30, 3, 2013. Crossref
-
UNDERWOOD C., VAN EPS A. W., ROSS M. W., LAVERMAN P., VAN BLOOIS L., STORM G., SCHAER T. P., Intravenous technetium-99m labelled PEG-liposomes in horses: A safety and biodistribution study, Equine Veterinary Journal, 44, 2, 2012. Crossref
-
Tosi Giovanni, Costantino Luca, Ruozi Barbara, Forni Flavio, Vandelli Maria Angela, Polymeric nanoparticles for the drug delivery to the central nervous system, Expert Opinion on Drug Delivery, 5, 2, 2008. Crossref
-
Schipper Meike L., Iyer Gopal, Koh Ai Leen, Cheng Zhen, Ebenstein Yuval, Aharoni Assaf, Keren Shay, Bentolila Laurent A., Li Jianquing, Rao Jianghong, Chen Xiaoyuan, Banin Uri, Wu Anna M., Sinclair Robert, Weiss Shimon, Gambhir Sanjiv S., Particle Size, Surface Coating, and PEGylation Influence the Biodistribution of Quantum Dots in Living Mice, Small, 5, 1, 2009. Crossref
-
Prokop Ales, Davidson Jeffrey M., Nanovehicular Intracellular Delivery Systems, Journal of Pharmaceutical Sciences, 97, 9, 2008. Crossref
-
Jiskoot Wim, van Schie Rianne M. F., Carstens Myrra G., Schellekens Huub, Immunological Risk of Injectable Drug Delivery Systems, Pharmaceutical Research, 26, 6, 2009. Crossref
-
BARRATT G, The artificial cell design: liposomes, in Artificial Cells, Cell Engineering and Therapy, 2007. Crossref
-
Goins Beth A, Radiolabeled lipid nanoparticles for diagnostic imaging, Expert Opinion on Medical Diagnostics, 2, 7, 2008. Crossref
-
Woodle Martin C., Lu Patrick Y., Nanoparticles deliver RNAi therapy, Materials Today, 8, 8, 2005. Crossref
-
Lowe Sean, O'Brien-Simpson Neil M., Connal Luke A., Antibiofouling polymer interfaces: poly(ethylene glycol) and other promising candidates, Polymer Chemistry, 6, 2, 2015. Crossref
-
Adams Nico, Schubert Ulrich S., Poly(2-oxazolines) in biological and biomedical application contexts, Advanced Drug Delivery Reviews, 59, 15, 2007. Crossref
-
Agashe H., Lagisetty P., Sahoo K., Bourne D., Grady B., Awasthi V., Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model, Journal of Nanoparticle Research, 13, 6, 2011. Crossref
-
Moghimi S.M., Szebeni J., Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties, Progress in Lipid Research, 42, 6, 2003. Crossref
-
Caron W P, Song G, Kumar P, Rawal S, Zamboni W C, Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier-Mediated Anticancer Agents, Clinical Pharmacology & Therapeutics, 91, 5, 2012. Crossref
-
Zaharoff David A., Rogers Connie J., Hance Kenneth W., Schlom Jeffrey, Greiner John W., Chitosan solution enhances the immunoadjuvant properties of GM-CSF, Vaccine, 25, 52, 2007. Crossref
-
Laverman Peter, Boerman Otto C, Re: Selective in vitro labeling of white blood cells using 99mTc-labeled liposomes, Nuclear Medicine and Biology, 29, 5, 2002. Crossref
-
Li Peiyong, Tan Zhonghua, Zhu Yihua, Chen Suyun, Ding Shuli, Zhuang Hongming, Targeting study of gelatin adsorbed clodronate in reticuloendothelial system and its potential application in immune thrombocytopenic purpura of rat model, Journal of Controlled Release, 114, 2, 2006. Crossref
-
Soepenberg O., Sparreboom A., de Jonge M.J.A., Planting A.S.Th., de Heus G., Loos W.J., Hartman C.M., Bowden C., Verweij J., Real-time pharmacokinetics guiding clinical decisions, European Journal of Cancer, 40, 5, 2004. Crossref
-
Lu Wei, Wan Jin, She Zhenjue, Jiang Xinguo, Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle, Journal of Controlled Release, 118, 1, 2007. Crossref
-
Calin Manuela, Immunoliposomes for Specific Drug Delivery, in Antibody-Mediated Drug Delivery Systems, 2012. Crossref
-
Movassaghian Sara, Torchilin Vladimir P., Long-Circulating Therapies for Cancer Treatment, in Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies, 2015. Crossref
-
Ishida Tatsuhiro, Ichihara Masako, Wang XinYu, Yamamoto Kenji, Kimura Junji, Majima Eiji, Kiwada Hiroshi, Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes, Journal of Controlled Release, 112, 1, 2006. Crossref
-
Paukner Susanne, Kohl Gudrun, Jalava Katri, Lubitz Werner, Sealed Bacterial Ghosts—Novel Targeting Vehicles for Advanced Drug Delivery of Water-soluble Substances, Journal of Drug Targeting, 11, 3, 2003. Crossref
-
Abe Hideki, Fujihara Mitsuhiro, Azuma Hiroshi, Ikeda Hisami, Ikebuchi Kenji, Takeoka Shinji, Tsuchida Eishun, Harashima Hideyoshi, Interaction of Hemoglobin Vesicles, a Cellular-Type Artificial Oxygen Carrier, with Human Plasma: Effects on Coagulation, Kallikrein-Kinin, and Complement Systems, Artificial Cells, Blood Substitutes, and Biotechnology, 34, 1, 2006. Crossref
-
Bissadi G., Weberskirch R., Formation of polyoxazoline-silica nanoparticles via the surface-initiated cationic polymerization of 2-methyl-2-oxazoline, Polymer Chemistry, 7, 32, 2016. Crossref
-
Azzopardi Ernest A., Conlan R. Steven, Whitaker Iain S., Polymer therapeutics in surgery: the next frontier, Journal of Interdisciplinary Nanomedicine, 1, 1, 2016. Crossref
-
Bodo Michael, Szebeni Janos, Baranyi Lajos, Savay Sandor, Pearce Frederick J., Alving Carl R., Bünger Rolf, Cerebrovascular Involvement in Liposome—Induced Cardiopulmonary Distress in Pigs, Journal of Liposome Research, 15, 1-2, 2005. Crossref
-
Yan Xuedong, Scherphof Gerrit L., Kamps Jan A. A. M., Liposome Opsonization, Journal of Liposome Research, 15, 1-2, 2005. Crossref
-
Yang Yannan, Yu Chengzhong, Advances in silica based nanoparticles for targeted cancer therapy, Nanomedicine: Nanotechnology, Biology and Medicine, 12, 2, 2016. Crossref
-
Tyson Rachel, Osae Leah, Madden Andrew J., Lucas Andrew T., Zamboni William C., Translation to the Clinic: Preclinical and Clinical Pharmacology Studies of Nanoparticles - The Translational Challenge, in Pharmaceutical Nanotechnology: Innovation and Production, 2016. Crossref
-
Nagarsenker Mangal Shailesh, Marwah Megha Sunil, Liposomes, in Novel Approaches for Drug Delivery, 2017. Crossref
-
Constantinescu Iren, Levin Elena, Gyongyossy‐Issa Maria, Liposomes and Blood Cells: A Flow Cytometric Study, Artificial Cells, Blood Substitutes, and Biotechnology, 31, 4, 2003. Crossref
-
Abe Hideki, Azuma Hiroshi, Yamaguchi Miki, Fujihara Mitsuhiro, Ikeda Hisami, Sakai Hiromi, Takeoka Shinji, Tsuchida Eishun, Effects of Hemoglobin Vesicles, a Liposomal Artificial Oxygen Carrier, on Hematological Responses, Complement and Anaphylactic Reactions in Rats, Artificial Cells, Blood Substitutes, and Biotechnology, 35, 2, 2007. Crossref
-
Vlasova Maria, Smirin Boris V., Personalized Approach in Nanomedicine, in Recent Advances in Drug Delivery Technology, 2017. Crossref
-
Vlasova Maria, Smirin Boris V., Personalized Approach in Nanomedicine, in Biomedical Engineering, 2018. Crossref
-
Schorzman Allison N., Lucas Andrew T., Kagel John R., Zamboni William C., Methods and Study Designs for Characterizing the Pharmacokinetics and Pharmacodynamics of Carrier-Mediated Agents, in Targeted Drug Delivery, 1831, 2018. Crossref
-
Bourquin Joël, Milosevic Ana, Hauser Daniel, Lehner Roman, Blank Fabian, Petri-Fink Alke, Rothen-Rutishauser Barbara, Biodistribution, Clearance, and Long-Term Fate of Clinically Relevant Nanomaterials, Advanced Materials, 30, 19, 2018. Crossref
-
Phillips William, Goins Beth, Bao Ande, Long-Circulating Liposomes with Attached Diagnostic Moieties: Application for Gamma and MR Imaging, in Multifunctional Pharmaceutical Nanocarriers, 4, 2008. Crossref
-
Han Hyun Jee, Ekweremadu Chinedu, Patel Nairuti, Advanced drug delivery system with nanomaterials for personalised medicine to treat breast cancer, Journal of Drug Delivery Science and Technology, 52, 2019. Crossref
-
Mare Rosario, Da Huining, Fresta Massimo, Cosco Donato, Awasthi Vibhudutta, Anchoring Property of a Novel Hydrophilic Lipopolymer, HDAS-SHP, Post-Inserted in Preformed Liposomes, Nanomaterials, 9, 9, 2019. Crossref
-
Taguchi Kazuaki, Ogaki Shigeru, Watanabe Hiroshi, Kadowaki Daisuke, Sakai Hiromi, Kobayashi Koichi, Horinouchi Hirohisa, Maruyama Toru, Otagiri Masaki, Fluid Resuscitation with Hemoglobin Vesicles Prevents Escherichia coli Growth via Complement Activation in a Hemorrhagic Shock Rat Model, Journal of Pharmacology and Experimental Therapeutics, 337, 1, 2011. Crossref
-
Trucillo Paolo, Reverchon Ernesto, Production of PEG-coated liposomes using a continuous supercritical assisted process, The Journal of Supercritical Fluids, 167, 2021. Crossref
-
Walduck Anna, Sangwan Parveen, Vo Quynh Anh, Ratcliffe Julian, White Jacinta, Muir Benjamin W., Tran Nhiem, Treatment of Staphylococcus aureus skin infection in vivo using rifampicin loaded lipid nanoparticles, RSC Advances, 10, 55, 2020. Crossref
-
Petschauer Jennifer S, Madden Andrew J, Kirschbrown Whitney P, Song Gina, Zamboni William C, The effects of nanoparticle drug loading on the pharmacokinetics of anticancer agents, Nanomedicine, 10, 3, 2015. Crossref
-
Metselaar Josbert M., Bruin Peter, de Boer Leo W. T., de Vringer Tom, Snel Cor, Oussoren Christien, Wauben Marca H. M., Crommelin Daan J. A., Storm Gert, Hennink Wim E., A Novel Family of l-Amino Acid-Based Biodegradable Polymer−Lipid Conjugates for the Development of Long-Circulating Liposomes with Effective Drug-Targeting Capacity, Bioconjugate Chemistry, 14, 6, 2003. Crossref
-
Wei Xue-Qin, Ba Kai, Construction a Long-Circulating Delivery System of Liposomal Curcumin by Coating Albumin, ACS Omega, 5, 27, 2020. Crossref
-
Gabizon Alberto, Szebeni Janos, Complement Activation: A Potential Threat on the Safety of Poly(ethylene glycol)-Coated Nanomedicines, ACS Nano, 14, 7, 2020. Crossref
-
Sheikholeslami Behjat, Lam Nga Wing, Dua Kamal, Haghi Mehra, Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate, Life Sciences, 300, 2022. Crossref
-
Lindner Lars H., Eichhorn Martin E., Eibl Hansjoerg, Teichert Nicole, Schmitt-Sody Marcus, Issels Rolf D., Dellian Marc, Novel Temperature-Sensitive Liposomes with Prolonged Circulation Time, Clinical Cancer Research, 10, 6, 2004. Crossref
-
Lammers Twan, Rizzo Larissa Y., Storm Gert, Kiessling Fabian, Personalized Nanomedicine, Clinical Cancer Research, 18, 18, 2012. Crossref